Target Price | HK$13.39 |
Price | HK$11.59 |
Potential |
15.51%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target China Tower 2026 .
The average China Tower target price is HK$13.39.
This is
15.51%
register free of charge
HK$16.80
44.95%
register free of charge
HK$12.12
4.57%
register free of charge
|
|
A rating was issued by 15 analysts: 11 Analysts recommend China Tower to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the China Tower stock has an average upside potential 2026 of
15.51%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HK$ | 106.84 | 111.50 |
4.00% | 4.36% | |
EBITDA Margin | 67.54% | 66.26% |
0.71% | 1.89% | |
Net Margin | 10.97% | 11.77% |
5.81% | 7.26% |
11 Analysts have issued a sales forecast China Tower 2025 . The average China Tower sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an China Tower EBITDA forecast 2025. The average China Tower EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 China Tower Analysts have issued a net profit forecast 2025. The average China Tower net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HK$ | 0.67 | 0.75 |
9.84% | 11.94% | |
P/E | 15.55 | |
EV/Sales | 2.55 |
11 Analysts have issued a China Tower forecast for earnings per share. The average China Tower EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.